Title: Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients
with Crohn’s disease and ulcerative colitis included in randomised controlled trials
Version: 4 Date: 01 Feb 2024
Reviewer's report:
accept in the present fromat
Title: Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients
with Crohn’s disease and ulcerative colitis included in randomised controlled trials
Version: 4 Date: 01 Feb 2024
Reviewer's report:
accept in the present fromat
Please review this paper.
user
Title: Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients
with Crohn’s disease and ulcerative colitis included in randomised controlled trials
Version: 4 Date: 01 Feb 2024
Reviewer's report:
accept in the present fromat
assistant